Sign in
Active, not recruitingPhase 1/2

An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB

Key facts

Who runs it
JCR Pharmaceuticals Co., Ltd.
Where
Japan4 sites in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
Phase
Phase 1/2
People taking part
10 people, planned
Started
5 Nov 2024
Expected to end
30 Apr 2030
Type of study
Interventional
Treatments tested
  • JR-446
Record updated
1 October 2026

Who can take part

Age
Up to 17 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Chronological age of <18 years
  • Confirmed diagnosis of MPS IIIB

Who cannot take part

  • Prior experience to gene therapy or HSCT with successful engraftment
  • Past use of another investigational drug or product in last 4 months or 5 half-lives (whichever is longer) before signing ICF
  • Past use of Genistein or Kineret (anakinra) within 4 months before signing ICF
  • Serious drug allergy or hypersensitivity
  • History of bleeding disorder or current use of medications that, in the opinion of the investigator, place them at risk of bleeding following lumbar puncture; The above information is not intended to contain all considerations relevant to a patient's potential participation in this clinical trial
  • Current participation in a clinical trial or past participation (within 30 days of enrolment into this study) in a study involving invasive procedures
  • Contraindication for lumbar puncture or MRI

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

A Phase I/ II, open-label study, designed to evaluate the safety and explore efficacy of the study drug in development for the treatment of MPS IIIB patients.

The group in the trial

  • JR-446Treatment being tested

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
1 October 2026